Shield Therapeutics plc (STX.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 86.81M |
| Enterprise Value | 105.33M |
| P/E Ratio | -3.06 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 1.11 |
| Price/Book Ratio | -3.76 |
| Enterprise/Revenue | 1.48 |
| Enterprise/EBITDA | -8.24 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -0.36 |
| Operating Margin | -0.2 |
AD
Management Effectiveness
| Return On Assets | -0.28 |
| Return On Equity | 1.22 |
Income Statement
| Revenue | 50.74M |
| Revenue/Share | 0.05 |
| Gross Profit | 22.38M |
| EBITDA | -9.16M |
| Net Income | -18.03M |
| Diluted EPS | -0.02 |
Balance Sheet
| Total Cash | 11.63M |
| Total Cash/Share | 0.01 |
| Total Debt | 30.15M |
| Total Debt/Equity | -2 |
| Current Ratio | 0.9 |
| Book Value Per Share | -0.01 |
Price History
| 52-Week Change | -12.22 |
| 52-Week High | 12.5 |
| 52-Week Low | 3.8 |
| Moving Average 50 Days | 6.07 |
| Moving Average 200 Days | 8.31 |
Statistics
| Average Volume | 2.27M |
| Shares Outstanding | 1.07B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1029:1000 |
| Last Split Date | December 16, 2022 |
AD
